See more : Indo Amines Limited (INDOAMIN.NS) Income Statement Analysis – Financial Results
Complete financial analysis of HCA Healthcare, Inc. (HCA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HCA Healthcare, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Alamos Gold Inc. (AGI) Income Statement Analysis – Financial Results
- Zhejiang Wanma Co., Ltd. (002276.SZ) Income Statement Analysis – Financial Results
- ARYZTA AG (0MFY.L) Income Statement Analysis – Financial Results
- Big Banc Split Corp. (BNK.TO) Income Statement Analysis – Financial Results
- DCP Midstream, LP (DCP-PC) Income Statement Analysis – Financial Results
HCA Healthcare, Inc. (HCA)
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.97B | 60.23B | 58.75B | 51.53B | 51.34B | 46.68B | 43.61B | 41.49B | 39.68B | 36.92B | 34.18B | 33.01B | 32.51B | 30.68B | 30.05B | 28.37B | 26.86B | 25.48B | 24.46B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 10.25B | 761.60M | 461.00M | 272.60M |
| Cost of Revenue | 55.34B | 9.37B | 9.48B | 8.37B | 8.48B | 7.72B | 7.32B | 6.93B | 6.64B | 6.26B | 5.97B | 5.72B | 5.18B | 4.96B | 16.83B | 4.62B | 4.40B | 4.32B | 4.13B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.51B | 230.50M | 135.30M | 81.30M |
| Gross Profit | 9.63B | 50.86B | 49.27B | 43.16B | 42.86B | 38.95B | 36.30B | 34.56B | 33.04B | 30.66B | 28.21B | 27.30B | 27.33B | 25.72B | 13.23B | 23.75B | 22.46B | 21.16B | 20.33B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 6.74B | 531.10M | 325.70M | 191.30M |
| Gross Profit Ratio | 14.82% | 84.44% | 83.86% | 83.76% | 83.48% | 83.45% | 83.23% | 83.29% | 83.27% | 83.04% | 82.53% | 82.68% | 84.07% | 83.83% | 44.01% | 83.72% | 83.64% | 83.04% | 83.13% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 65.74% | 69.73% | 70.65% | 70.18% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 9.42B | 8.68B | 7.95B | 7.28B | 6.64B | 6.75B | 7.81B | 7.63B | 7.84B | 7.10B | 0.00 | 4.76B | 452.00M | 283.40M | 162.20M |
| Other Expenses | 0.00 | 14.12B | 12.81B | 12.03B | 12.08B | 10.89B | -466.00M | -430.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 45.44B | 41.81B | 39.59B | 35.90B | 35.64B | 32.31B | 30.24B | 28.36B | 27.08B | 25.09B | 23.42B | 22.48B | 22.99B | 21.56B | 9.19B | 20.82B | 19.31B | 18.08B | 17.43B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 5.36B | 490.30M | 305.90M | 174.10M |
| Cost & Expenses | 55.34B | 51.18B | 49.07B | 44.27B | 44.12B | 40.04B | 37.56B | 35.29B | 33.71B | 31.35B | 29.39B | 28.20B | 28.17B | 26.52B | 26.02B | 25.44B | 23.70B | 22.40B | 21.55B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 8.87B | 720.80M | 441.20M | 255.40M |
| Interest Income | 0.00 | 1.74B | 1.57B | 1.58B | 1.82B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.94B | 1.74B | 1.57B | 1.58B | 1.82B | 1.76B | 1.69B | 1.71B | 1.67B | 1.74B | 1.85B | 1.80B | 2.04B | 2.10B | 1.99B | 2.02B | 2.22B | 955.00M | 655.00M | 563.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.08B | 2.97B | 2.85B | 2.72B | 2.60B | 2.28B | 2.13B | 1.97B | 1.90B | 1.82B | 1.75B | 1.68B | 1.47B | 1.42B | 1.43B | 1.42B | 1.43B | 1.39B | 1.37B | 1.25B | 1.11B | 1.01B | 1.05B | 1.03B | 1.09B | 1.25B | 1.24B | 1.16B | 981.00M | 609.00M | -599.00M | -38.30M | -22.50M | -11.90M |
| EBITDA | 12.72B | 13.29B | 14.25B | 9.74B | 9.66B | 9.37B | 8.20B | 8.48B | 7.53B | 7.04B | 6.55B | 6.37B | 7.06B | 5.75B | 5.07B | 4.61B | 4.83B | 4.21B | 4.36B | 3.95B | 4.04B | 3.08B | 3.29B | 2.43B | 3.30B | 18.68B | 2.85B | 4.31B | 3.33B | 2.12B | 2.07B | 21.40M | 3.90M | 11.40M |
| EBITDA Ratio | 19.58% | 20.03% | 21.52% | 19.48% | 19.20% | 19.17% | 18.88% | 19.81% | 19.95% | 20.12% | 19.23% | 19.78% | 18.65% | 19.12% | 18.16% | 14.51% | 17.07% | 17.54% | 16.04% | 16.88% | 18.52% | 15.60% | 18.69% | 14.60% | 19.82% | 19.93% | 15.89% | 21.64% | 18.84% | 19.02% | 20.17% | 2.81% | 0.85% | 4.18% |
| Operating Income | 9.63B | 9.10B | 9.79B | 7.32B | 7.26B | 6.64B | 6.10B | 6.25B | 6.01B | 5.61B | 4.82B | 4.85B | 4.60B | 4.45B | 4.03B | 2.70B | 3.16B | 3.08B | 2.55B | 2.72B | 2.93B | 2.07B | 2.31B | 1.40B | 2.21B | 2.48B | 1.75B | 3.15B | 2.35B | 1.51B | 2.67B | 59.70M | 26.40M | 23.30M |
| Operating Income Ratio | 14.82% | 15.10% | 16.66% | 14.20% | 14.14% | 14.23% | 13.99% | 15.07% | 15.15% | 15.19% | 14.10% | 14.70% | 14.14% | 14.49% | 13.42% | 9.52% | 11.76% | 12.08% | 10.42% | 11.56% | 13.42% | 10.48% | 12.85% | 8.40% | 13.25% | 13.25% | 9.32% | 15.84% | 13.29% | 13.55% | 26.01% | 7.84% | 5.73% | 8.55% |
| Total Other Income/Expenses | -1.92B | -473.00M | 155.00M | -1.83B | -1.97B | -1.31B | -1.68B | -1.39B | -1.96B | -1.96B | -1.62B | -1.92B | -777.00M | -1.93B | -1.80B | -1.77B | -1.76B | -974.00M | -577.00M | -743.00M | -771.00M | -594.00M | -720.00M | -16.04B | -15.21B | -15.81B | -783.00M | -456.00M | -930.00M | -277.00M | -415.00M | 1.90M | 5.20M | -3.70M |
| Income Before Tax | 7.71B | 8.58B | 9.83B | 5.43B | 5.24B | 5.34B | 4.38B | 4.81B | 3.96B | 3.48B | 2.95B | 2.89B | 3.56B | 2.23B | 2.00B | 941.00M | 1.19B | 1.66B | 2.15B | 1.97B | 2.16B | 1.46B | 1.51B | 516.00M | 1.23B | 1.08B | 388.00M | 2.52B | 1.78B | 1.23B | 969.00M | 42.70M | 25.00M | 13.50M |
| Income Before Tax Ratio | 11.86% | 14.24% | 16.74% | 10.54% | 10.22% | 11.43% | 10.04% | 11.59% | 9.97% | 9.43% | 8.62% | 8.77% | 10.95% | 7.27% | 6.66% | 3.32% | 4.43% | 6.52% | 8.79% | 8.40% | 9.89% | 7.37% | 8.38% | 3.10% | 7.37% | 5.79% | 2.06% | 12.63% | 10.05% | 11.06% | 9.45% | 5.61% | 5.42% | 4.95% |
| Income Tax Expense | 1.62B | 1.75B | 2.11B | 1.04B | 1.10B | 946.00M | 1.64B | 1.38B | 1.26B | 1.11B | 950.00M | 888.00M | 719.00M | 658.00M | 627.00M | 268.00M | 316.00M | 625.00M | 725.00M | 727.00M | 824.00M | 622.00M | 602.00M | 297.00M | 570.00M | 549.00M | 206.00M | 1.01B | 715.00M | 486.00M | 394.00M | 16.80M | 9.80M | 3.70M |
| Net Income | 5.24B | 5.64B | 6.96B | 3.75B | 3.51B | 3.79B | 2.22B | 2.89B | 2.13B | 1.88B | 1.56B | 1.61B | 2.47B | 1.21B | 1.05B | 673.00M | 874.00M | 1.04B | 1.42B | 1.25B | 1.33B | 833.00M | 886.00M | 219.00M | 657.00M | 379.00M | -305.00M | 1.51B | 961.00M | 630.00M | 507.00M | 25.50M | 15.20M | 9.80M |
| Net Income Ratio | 8.07% | 9.37% | 11.84% | 7.28% | 6.83% | 8.11% | 5.08% | 6.97% | 5.37% | 5.08% | 4.55% | 4.86% | 7.58% | 3.93% | 3.51% | 2.37% | 3.25% | 4.07% | 5.82% | 5.30% | 6.11% | 4.22% | 4.94% | 1.31% | 3.94% | 2.03% | -1.62% | 7.56% | 5.43% | 5.66% | 4.95% | 3.35% | 3.30% | 3.60% |
| EPS | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 11.04 | 6.33 | 7.80 | 5.34 | 4.46 | 3.54 | 3.62 | 5.17 | 2.83 | 3.08 | 1.97 | 2.56 | 2.57 | 3.24 | 2.62 | 2.66 | 1.63 | 1.69 | 0.39 | 1.12 | 0.73 | -0.46 | 2.24 | 1.44 | 1.80 | 1.05 | 0.78 | 0.61 | 0.55 |
| EPS Diluted | 18.96 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 | 7.30 | 4.99 | 4.16 | 3.37 | 3.49 | 4.97 | 2.76 | 3.02 | 1.93 | 2.51 | 2.53 | 3.18 | 2.58 | 2.61 | 1.59 | 1.65 | 0.39 | 1.11 | 0.73 | -0.46 | 2.22 | 1.43 | 1.80 | 1.03 | 0.78 | 0.61 | 0.55 |
| Weighted Avg Shares Out | 272.40M | 290.35M | 323.32M | 338.27M | 341.21M | 342.90M | 350.09M | 370.54M | 398.74M | 420.48M | 439.60M | 443.20M | 476.61M | 426.42M | 341.93M | 341.93M | 341.93M | 403.40M | 440.02M | 475.62M | 500.75M | 511.04M | 524.26M | 748.72M | 660.71M | 645.21M | 663.04M | 671.88M | 667.36M | 350.00M | 482.86M | 32.69M | 24.92M | 17.82M |
| Weighted Avg Shares Out (Dil) | 276.41M | 294.67M | 328.75M | 343.61M | 348.23M | 355.30M | 372.22M | 395.85M | 426.72M | 450.35M | 461.91M | 459.40M | 495.94M | 437.35M | 348.71M | 348.71M | 348.71M | 410.21M | 447.50M | 483.66M | 510.34M | 523.90M | 536.97M | 748.72M | 666.67M | 645.21M | 663.04M | 677.93M | 672.03M | 516.67M | 492.23M | 32.69M | 24.92M | 17.82M |
New Strong Buy Stocks for September 20th
QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
HCA benefits from expanding insurance coverage, rising demand and improving margins.
4 GARP Stocks to Scoop up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.
HCA Healthcare (HCA) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for September 12th
AFRM, SBSI, LYTS, CM and HCA have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2024.
2 Sector ETFs & Stocks to Bet on Following August Jobs Data
The U.S. economy added 142, 000 jobs in August 2024, more than a downwardly revised 89, 000 in July but below forecasts of 160, 000.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
Here is how HCA Healthcare (HCA) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
5 Dividend Growth Stocks to Buy in Historically Weak September
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Source: https://incomestatements.info
Category: Stock Reports